|Articles|May 27, 2016
Valeant Rejected Takeda Bid
May 27, 2016.
Advertisement
Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.
The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.
More on the story
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner
2
How Elevated Cortisol Levels Can Impact Type II Diabetes Treatments
3
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
4
IBD's Most Persistent Gap: Q&A with Christian Thienel
5